Newsletters
Egypt and Türkiye moved to deepen cooperation in pharmaceutical manufacturing, biotechnology, and broader health-sector development as senior officials from both countries met in Ankara this week.
The officials discussed plans for expanded industrial collaboration and the exchange of technological expertise. They noted that Egypt represents a promising regional market, while the Turkish side expressed interest in expanding industrial cooperation and transferring technological expertise, according to a statement by the Egyptian Health Ministry.
This came during the minister’s meeting with a high-level delegation from the Union of Chambers and Commodity Exchanges of Türkiye, attended by officials from the Egyptian Drug Authority and the Unified Procurement Authority, on the sidelines of the 11th World Medical Congress held in Ankara. The event concluded on Thursday.
In Ankara, Turkish Health Minister Kemal Memisoglu held a meeting with his Egyptian counterpart Khaled Abdel Ghaffar on the sidelines of the 11th Turkish Medical World Forum.
Memisoglu said in a post on his social media account that the two sides discussed steps to strengthen health cooperation between the two countries and exchanged views on the next phase. He expressed hope that the talks would lead to positive outcomes.
Ghaffar highlighted several of Egypt’s recent health achievements, including the elimination of hepatitis C and trachoma, as well as Egypt’s declaration as malaria-free.
Meanwhile, Ministry spokesperson Hossam Abdel Ghaffar said the meeting addressed boosting cooperation between the two countries in health infrastructure and digital transformation. It also covered smart hospitals, telemedicine units, and technology transfer. Local production of pharmaceuticals—including cancer drugs, biosimilars, and vaccines—was another key topic.
In a separate context, the Health Ministry announced that 21,986 medical services were provided to senior citizens at geriatric psychiatry clinics across 12 hospitals between January and November.
4 min read
